Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 505 to 510 of 510 entries
Sorted by: Best Match Show Resources per page
Protecting against researcher bias in secondary data analysis: challenges and potential solutions.

European journal of epidemiology

Baldwin JR, Pingault JB, Schoeler T, Sallis HM, Munafò MR.
PMID: 35025022
Eur J Epidemiol. 2022 Jan 13; doi: 10.1007/s10654-021-00839-0. Epub 2022 Jan 13.

Analysis of secondary data sources (such as cohort studies, survey data, and administrative records) has the potential to provide answers to science and society's most pressing questions. However, researcher biases can lead to questionable research practices in secondary data...

Cite
Baldwin JR, Pingault JB, Schoeler T, et al. Protecting against researcher bias in secondary data analysis: challenges and potential solutions. Eur J Epidemiol. 2022;doi: 10.1007/s10654-021-00839-0.
Baldwin, J. R., Pingault, J. B., Schoeler, T., Sallis, H. M., & Munafò, M. R. (2022). Protecting against researcher bias in secondary data analysis: challenges and potential solutions. European journal of epidemiology, . https://doi.org/10.1007/s10654-021-00839-0
Baldwin, Jessie R, et al. "Protecting against researcher bias in secondary data analysis: challenges and potential solutions." European journal of epidemiology vol. (2022). doi: https://doi.org/10.1007/s10654-021-00839-0
Baldwin JR, Pingault JB, Schoeler T, Sallis HM, Munafò MR. Protecting against researcher bias in secondary data analysis: challenges and potential solutions. Eur J Epidemiol. 2022 Jan 13; doi: 10.1007/s10654-021-00839-0. Epub 2022 Jan 13. PMID: 35025022.
Copy Download .nbib Format: NLM
Post-translational insertion of boron in proteins to probe and modulate function.

Nature chemical biology

Mollner TA, Isenegger PG, Josephson B, Buchanan C, Lercher L, Oehlrich D, Hansen DF, Mohammed S, Baldwin AJ, Gouverneur V, Davis BG.
PMID: 34725511
Nat Chem Biol. 2021 Dec;17(12):1245-1261. doi: 10.1038/s41589-021-00883-7. Epub 2021 Nov 01.

Boron is absent in proteins, yet is a micronutrient. It possesses unique bonding that could expand biological function including modes of Lewis acidity not available to typical elements of life. Here we show that post-translational Cβ-Bγ bond formation provides...

Cite
Mollner TA, Isenegger PG, Josephson B, et al. Post-translational insertion of boron in proteins to probe and modulate function. Nat Chem Biol. 2021;17(12):1245-1261doi: 10.1038/s41589-021-00883-7.
Mollner, T. A., Isenegger, P. G., Josephson, B., Buchanan, C., Lercher, L., Oehlrich, D., Hansen, D. F., Mohammed, S., Baldwin, A. J., Gouverneur, V., & Davis, B. G. (2021). Post-translational insertion of boron in proteins to probe and modulate function. Nature chemical biology, 17(12), 1245-1261. https://doi.org/10.1038/s41589-021-00883-7
Mollner, Tim A, et al. "Post-translational insertion of boron in proteins to probe and modulate function." Nature chemical biology vol. 17,12 (2021): 1245-1261. doi: https://doi.org/10.1038/s41589-021-00883-7
Mollner TA, Isenegger PG, Josephson B, Buchanan C, Lercher L, Oehlrich D, Hansen DF, Mohammed S, Baldwin AJ, Gouverneur V, Davis BG. Post-translational insertion of boron in proteins to probe and modulate function. Nat Chem Biol. 2021 Dec;17(12):1245-1261. doi: 10.1038/s41589-021-00883-7. Epub 2021 Nov 01. PMID: 34725511; PMCID: PMC8604732.
Copy Download .nbib Format: NLM
Cognitive ability and metabolic physical health in first-episode psychosis.

Schizophrenia research. Cognition

Whitson S, O'Donoghue B, Hester R, Baldwin L, Harrigan S, Francey S, Graham J, Nelson B, Ratheesh A, Alvarez-Jimenez M, Fornito A, Pantelis C, Yuen HP, Thompson A, Kerr M, Berk M, Wood SJ, McGorry P, Allott K.
PMID: 33659191
Schizophr Res Cogn. 2021 Feb 13;24:100194. doi: 10.1016/j.scog.2021.100194. eCollection 2021 Jun.

Cognitive impairments are a core feature of first-episode psychosis (FEP), arising before illness onset and antipsychotic exposure. Individuals with chronic psychosis experience poorer physical health while taking antipsychotic medication, but health disparities may be evident at FEP onset, prior...

Cite
Whitson S, O'Donoghue B, Hester R, et al. Cognitive ability and metabolic physical health in first-episode psychosis. Schizophr Res Cogn. 2021;24:100194doi: 10.1016/j.scog.2021.100194.
Whitson, S., O'Donoghue, B., Hester, R., Baldwin, L., Harrigan, S., Francey, S., Graham, J., Nelson, B., Ratheesh, A., Alvarez-Jimenez, M., Fornito, A., Pantelis, C., Yuen, H. P., Thompson, A., Kerr, M., Berk, M., Wood, S. J., McGorry, P., & Allott, K. (2021). Cognitive ability and metabolic physical health in first-episode psychosis. Schizophrenia research. Cognition, 24100194. https://doi.org/10.1016/j.scog.2021.100194
Whitson, Sarah, et al. "Cognitive ability and metabolic physical health in first-episode psychosis." Schizophrenia research. Cognition vol. 24 (2021): 100194. doi: https://doi.org/10.1016/j.scog.2021.100194
Whitson S, O'Donoghue B, Hester R, Baldwin L, Harrigan S, Francey S, Graham J, Nelson B, Ratheesh A, Alvarez-Jimenez M, Fornito A, Pantelis C, Yuen HP, Thompson A, Kerr M, Berk M, Wood SJ, McGorry P, Allott K. Cognitive ability and metabolic physical health in first-episode psychosis. Schizophr Res Cogn. 2021 Feb 13;24:100194. doi: 10.1016/j.scog.2021.100194. eCollection 2021 Jun. PMID: 33659191; PMCID: PMC7895837.
Copy Download .nbib Format: NLM
Research, Practice, and Policy Implications of Adverse Childhood Events-Reply.

JAMA pediatrics

Baldwin JR, Danese A.
PMID: 33970203
JAMA Pediatr. 2021 Aug 01;175(8):867-868. doi: 10.1001/jamapediatrics.2021.0813.

No abstract available.

Cite
Baldwin JR, Danese A. Research, Practice, and Policy Implications of Adverse Childhood Events-Reply. JAMA Pediatr. 2021;175(8):867-868doi: 10.1001/jamapediatrics.2021.0813.
Baldwin, J. R., & Danese, A. (2021). Research, Practice, and Policy Implications of Adverse Childhood Events-Reply. JAMA pediatrics, 175(8), 867-868. https://doi.org/10.1001/jamapediatrics.2021.0813
Baldwin, Jessie R, and Danese, Andrea. "Research, Practice, and Policy Implications of Adverse Childhood Events-Reply." JAMA pediatrics vol. 175,8 (2021): 867-868. doi: https://doi.org/10.1001/jamapediatrics.2021.0813
Baldwin JR, Danese A. Research, Practice, and Policy Implications of Adverse Childhood Events-Reply. JAMA Pediatr. 2021 Aug 01;175(8):867-868. doi: 10.1001/jamapediatrics.2021.0813. PMID: 33970203.
Copy Download .nbib Format: NLM
Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies.

The Journal of infection

Owen SI, Williams CT, Garrod G, Fraser AJ, Baldwin L, Brown L, Byrne RL, Collins AM, Cubas-Atienzar AI, de Vos M, Edwards T, Escadafal C, Ferreira DM, Fletcher T, Hyder-Wright A, Kay GA, Kontogianni K, Mason J, Menzies S, Mitsi E, Planche T, Sacks JA, Taylor J, Todd S, Tully C, Cuevas LE, Adams ER.
PMID: 34906597
J Infect. 2021 Dec 11; doi: 10.1016/j.jinf.2021.12.007. Epub 2021 Dec 11.

BACKGROUND: There are an abundance of commercially available lateral flow assays (LFAs) that detect antibodies to SARS-CoV-2. Whilst these are usually evaluated by the manufacturer, externally performed diagnostic accuracy studies to assess performance are essential. Herein we present an...

Cite
Owen SI, Williams CT, Garrod G, et al. Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies. J Infect. 2021;doi: 10.1016/j.jinf.2021.12.007.
Owen, S. I., Williams, C. T., Garrod, G., Fraser, A. J., Baldwin, L., Brown, L., Byrne, R. L., Collins, A. M., Cubas-Atienzar, A. I., de Vos, M., Edwards, T., Escadafal, C., Ferreira, D. M., Fletcher, T., Hyder-Wright, A., Kay, G. A., Kontogianni, K., Mason, J., Menzies, S., Mitsi, E., Planche, T., Sacks, J. A., Taylor, J., Todd, S., Tully, C., Cuevas, L. E., & Adams, E. R. (2021). Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies. The Journal of infection, . https://doi.org/10.1016/j.jinf.2021.12.007
Owen, Sophie I, et al. "Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies." The Journal of infection vol. (2021). doi: https://doi.org/10.1016/j.jinf.2021.12.007
Owen SI, Williams CT, Garrod G, Fraser AJ, Baldwin L, Brown L, Byrne RL, Collins AM, Cubas-Atienzar AI, de Vos M, Edwards T, Escadafal C, Ferreira DM, Fletcher T, Hyder-Wright A, Kay GA, Kontogianni K, Mason J, Menzies S, Mitsi E, Planche T, Sacks JA, Taylor J, Todd S, Tully C, Cuevas LE, Adams ER. Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies. J Infect. 2021 Dec 11; doi: 10.1016/j.jinf.2021.12.007. Epub 2021 Dec 11. PMID: 34906597; PMCID: PMC8664720.
Copy Download .nbib Format: NLM
Analytical and Clinical Evaluation of the Semiquantitative Elecsys Anti-SARS-CoV-2 Spike Protein Receptor Binding Domain Antibody Assay on the Roche cobas e602 Analyzer.

American journal of clinical pathology

Chan CW, Yi X, Lenza M, Baldwin AD, Jakalski J, Tesic V, Yeo KJ.
PMID: 34463315
Am J Clin Pathol. 2022 Jan 06;157(1):109-118. doi: 10.1093/ajcp/aqab092.

OBJECTIVES: To analytically and clinically evaluate the semiquantitative Elecsys anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody (S-Ab) assay on the Roche cobas e602 analyzer.METHODS: The S-Ab assay is a 1-step, double-antigen sandwich electrochemiluminescent immunoassay that semiquantitatively...

Cite
Chan CW, Yi X, Lenza M, et al. Analytical and Clinical Evaluation of the Semiquantitative Elecsys Anti-SARS-CoV-2 Spike Protein Receptor Binding Domain Antibody Assay on the Roche cobas e602 Analyzer. Am J Clin Pathol. 2022;157(1):109-118doi: 10.1093/ajcp/aqab092.
Chan, C. W., Yi, X., Lenza, M., Baldwin, A. D., Jakalski, J., Tesic, V., & Yeo, K. J. (2022). Analytical and Clinical Evaluation of the Semiquantitative Elecsys Anti-SARS-CoV-2 Spike Protein Receptor Binding Domain Antibody Assay on the Roche cobas e602 Analyzer. American journal of clinical pathology, 157(1), 109-118. https://doi.org/10.1093/ajcp/aqab092
Chan, Clarence W, et al. "Analytical and Clinical Evaluation of the Semiquantitative Elecsys Anti-SARS-CoV-2 Spike Protein Receptor Binding Domain Antibody Assay on the Roche cobas e602 Analyzer." American journal of clinical pathology vol. 157,1 (2022): 109-118. doi: https://doi.org/10.1093/ajcp/aqab092
Chan CW, Yi X, Lenza M, Baldwin AD, Jakalski J, Tesic V, Yeo KJ. Analytical and Clinical Evaluation of the Semiquantitative Elecsys Anti-SARS-CoV-2 Spike Protein Receptor Binding Domain Antibody Assay on the Roche cobas e602 Analyzer. Am J Clin Pathol. 2022 Jan 06;157(1):109-118. doi: 10.1093/ajcp/aqab092. PMID: 34463315; PMCID: PMC8499855.
Copy Download .nbib Format: NLM
Showing 505 to 510 of 510 entries